<DOC>
	<DOCNO>NCT00810862</DOCNO>
	<brief_summary>Primecrolimus cream 1 % effective treatment atopic dermatitis African American child .</brief_summary>
	<brief_title>Study Pimecrolimus Treatment Atopic Dermatitis African American Children</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>African American child age 2 17 year mild moderate atopic dermatitis mEASI le 3 baseline allergy Elidel component use oral steroid , immunosuppressive agent , cytostatics phototherapy within 4 week prior study . previous continuous noncontinuous use pimecrolimus tacrolimus great 11 month within 2 week enrollment . active skin infection . immunocompromised patient . previous history skin cancer lymphoma hypopigmentation study area pregnant breastfeed participation another investigational trial</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>African American child</keyword>
</DOC>